• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对暗化学物质和食品化学物质进行的共识虚拟筛选发现了严重急性呼吸综合征冠状病毒2主蛋白酶的潜在抑制剂。

Consensus virtual screening of dark chemical matter and food chemicals uncover potential inhibitors of SARS-CoV-2 main protease.

作者信息

Santibáñez-Morán Marisa G, López-López Edgar, Prieto-Martínez Fernando D, Sánchez-Cruz Norberto, Medina-Franco José L

机构信息

DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México Mexico City Mexico

Department of Pharmacology, Center of Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV) Mexico City Mexico.

出版信息

RSC Adv. 2020 Jul 1;10(42):25089-25099. doi: 10.1039/d0ra04922k. eCollection 2020 Jun 29.

DOI:10.1039/d0ra04922k
PMID:35517466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9055157/
Abstract

The pandemic caused by SARS-CoV-2 (COVID-19 disease) has claimed more than 500 000 lives worldwide, and more than nine million people are infected. Unfortunately, an effective drug or vaccine for its treatment is yet to be found. The increasing information available on critical molecular targets of SARS-CoV-2 and active compounds against related coronaviruses facilitates the proposal (or repurposing) of drug candidates for the treatment of COVID-19, with the aid of methods. As part of a global effort to fight the COVID-19 pandemic, herein we report a consensus virtual screening of extensive collections of food chemicals and compounds known as dark chemical matter. The rationale is to contribute to global efforts with a description of currently underexplored chemical space regions. The consensus approach included combining similarity searching with various queries and fingerprints, molecular docking with two docking protocols, and ADMETox profiling. We propose compounds commercially available for experimental testing. The full list of virtual screening hits is disclosed.

摘要

由严重急性呼吸综合征冠状病毒2(SARS-CoV-2,即新冠病毒病)引发的大流行已在全球造成超过50万人死亡,并有900多万人感染。不幸的是,尚未找到针对其治疗的有效药物或疫苗。关于SARS-CoV-2关键分子靶点和针对相关冠状病毒的活性化合物的信息不断增加,借助相关方法有助于提出(或重新利用)治疗新冠病毒病的候选药物。作为全球抗击新冠病毒病大流行努力的一部分,在此我们报告了对大量食品化学品和所谓的暗化学物质化合物集合进行的共识虚拟筛选。其基本原理是通过描述当前未充分探索的化学空间区域为全球努力做出贡献。共识方法包括将相似性搜索与各种查询和指纹相结合、使用两种对接协议进行分子对接以及进行ADMETox分析。我们提出了可用于实验测试的市售化合物。公开了虚拟筛选命中物的完整列表。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69a/9055157/fe5e349009c4/d0ra04922k-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69a/9055157/277afded64da/d0ra04922k-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69a/9055157/882a65351f77/d0ra04922k-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69a/9055157/fe5e349009c4/d0ra04922k-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69a/9055157/277afded64da/d0ra04922k-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69a/9055157/882a65351f77/d0ra04922k-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69a/9055157/fe5e349009c4/d0ra04922k-f3.jpg

相似文献

1
Consensus virtual screening of dark chemical matter and food chemicals uncover potential inhibitors of SARS-CoV-2 main protease.对暗化学物质和食品化学物质进行的共识虚拟筛选发现了严重急性呼吸综合征冠状病毒2主蛋白酶的潜在抑制剂。
RSC Adv. 2020 Jul 1;10(42):25089-25099. doi: 10.1039/d0ra04922k. eCollection 2020 Jun 29.
2
Searching for potential drugs against SARS-CoV-2 through virtual screening on several molecular targets.通过对多个分子靶点的虚拟筛选寻找针对 SARS-CoV-2 的潜在药物。
J Biomol Struct Dyn. 2022 Jul;40(11):5229-5242. doi: 10.1080/07391102.2020.1869096. Epub 2021 Jan 8.
3
Repurposing of Drugs for SARS-CoV-2 Using Inverse Docking Fingerprints.利用反向对接指纹图谱对用于治疗新型冠状病毒的药物进行重新利用。
Front Chem. 2021 Dec 28;9:757826. doi: 10.3389/fchem.2021.757826. eCollection 2021.
4
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.SARS-CoV-2 及其他人类致病冠状病毒的抗病毒药物和可用药靶的现状。
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
5
A multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease.多阶段虚拟筛选 FDA 批准药物揭示 SARS-CoV-2 主蛋白酶潜在抑制剂。
J Biomol Struct Dyn. 2022 Mar;40(5):2327-2338. doi: 10.1080/07391102.2020.1837680. Epub 2020 Oct 23.
6
Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target.基于电药效团的虚拟筛选、分子对接和分子动力学方法,针对主要蛋白酶靶点,对 SARS-CoV-2 进行药物重定位。
J Biomol Struct Dyn. 2021 Aug;39(13):4647-4658. doi: 10.1080/07391102.2020.1779819. Epub 2020 Jun 22.
7
Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds.通过对 6 亿种化合物的虚拟筛选鉴定出新型冠状病毒蛋白酶的潜在抑制剂。
Int J Mol Sci. 2020 May 21;21(10):3626. doi: 10.3390/ijms21103626.
8
Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.建立基于模拟的计算管道,以寻找针对 SARS-CoV-2 木瓜蛋白酶样蛋白酶的新型抑制性支架。
Molecules. 2021 Feb 20;26(4):1134. doi: 10.3390/molecules26041134.
9
Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns.2019冠状病毒病药物再利用计划的综合共识分析
J Chem Inf Model. 2021 Aug 23;61(8):3771-3788. doi: 10.1021/acs.jcim.1c00384. Epub 2021 Jul 27.
10
Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment.开发一种用于 COVID-19 治疗药物再利用的 SARS-CoV-2 主蛋白酶结合预测随机森林模型。
Exp Biol Med (Maywood). 2023 Nov;248(21):1927-1936. doi: 10.1177/15353702231209413. Epub 2023 Nov 24.

引用本文的文献

1
Probing the dark chemical matter against PDE4 for the management of psoriasis using in silico, in vitro and in vivo approach.采用计算机模拟、体外和体内方法探索针对磷酸二酯酶4治疗银屑病的潜在化学物质。
Mol Divers. 2025 Aug;29(4):3449-3464. doi: 10.1007/s11030-025-11159-w. Epub 2025 Mar 17.
2
Putative mechanism of a multivitamin treatment against insulin resistance.针对胰岛素抵抗的多种维生素治疗的推测机制。
Adipocyte. 2024 Dec;13(1):2369777. doi: 10.1080/21623945.2024.2369777. Epub 2024 Jun 27.
3
Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 M Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation.

本文引用的文献

1
Computational screening for potential drug candidates against the SARS-CoV-2 main protease.针对 SARS-CoV-2 主蛋白酶的潜在药物候选物的计算筛选。
F1000Res. 2020 Jun 4;9. doi: 10.12688/f1000research.23829.2. eCollection 2020.
2
QSAR Modeling of SARS-CoV M Inhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS-CoV-2.SARS-CoV M 抑制剂的定量构效关系建模将苏法戈利昔、西尼利尤单抗、普罗格来米特辛和其他药物鉴定为抗 SARS-CoV-2 再利用的候选药物。
Mol Inform. 2021 Jan;40(1):e2000113. doi: 10.1002/minf.202000113. Epub 2020 Aug 24.
3
In silico tools to study molecular targets of neglected diseases: inhibition of TcSir2rp3, an epigenetic enzyme of Trypanosoma cruzi.
揭示黑暗化学物质的奥秘:通过强化虚拟筛选和体外评估发现 SARS-CoV-2 M 主蛋白酶抑制剂。
Int J Mol Sci. 2024 Jun 1;25(11):6119. doi: 10.3390/ijms25116119.
4
Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2.吲哚类化合物作为 SARS-CoV-2 的潜在药物候选物。
Molecules. 2023 Sep 13;28(18):6603. doi: 10.3390/molecules28186603.
5
Consensus Virtual Screening Protocol Towards the Identification of Small Molecules Interacting with the Colchicine Binding Site of the Tubulin-microtubule System.针对与微管系统中的秋水仙素结合位点相互作用的小分子的共识虚拟筛选协议。
Mol Inform. 2023 Jan;42(1):e2200166. doi: 10.1002/minf.202200166. Epub 2022 Oct 19.
6
Progress and Impact of Latin American Natural Product Databases.拉丁美洲天然产物数据库的进展与影响。
Biomolecules. 2022 Aug 30;12(9):1202. doi: 10.3390/biom12091202.
7
Latin American databases of natural products: biodiversity and drug discovery against SARS-CoV-2.拉丁美洲天然产物数据库:生物多样性与抗SARS-CoV-2药物发现
RSC Adv. 2021 May 4;11(26):16051-16064. doi: 10.1039/d1ra01507a. eCollection 2021 Apr 26.
8
Predicting global diet-disease relationships at the atomic level: a COVID-19 case study.在原子水平上预测全球饮食与疾病的关系:以COVID-19为例的研究。
Curr Opin Food Sci. 2022 Apr;44:100804. doi: 10.1016/j.cofs.2021.12.013. Epub 2022 Jan 3.
9
Repurposing the antibacterial drugs for inhibition of SARS-CoV2-PLpro using molecular docking, MD simulation and binding energy calculation.利用分子对接、MD 模拟和结合能计算,重新利用抗菌药物抑制 SARS-CoV2-PLpro。
Mol Divers. 2022 Aug;26(4):2189-2209. doi: 10.1007/s11030-021-10325-0. Epub 2021 Sep 30.
10
Rapid Identification of Potential Drug Candidates from Multi-Million Compounds' Repositories. Combination of 2D Similarity Search with 3D Ligand/Structure Based Methods and In Vitro Screening.从数百万化合物库中快速鉴定潜在药物候选物。二维相似性搜索与三维配体/结构的方法相结合,并进行体外筛选。
Molecules. 2021 Sep 15;26(18):5593. doi: 10.3390/molecules26185593.
用于研究被忽视疾病分子靶点的计算工具:抑制 TcSir2rp3,即克氏锥虫的一种表观遗传酶。
Adv Protein Chem Struct Biol. 2020;122:203-229. doi: 10.1016/bs.apcsb.2020.04.001. Epub 2020 Jun 25.
4
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.猫冠状病毒药物可抑制新型冠状病毒的主要蛋白酶并阻断病毒复制。
Nat Commun. 2020 Aug 27;11(1):4282. doi: 10.1038/s41467-020-18096-2.
5
ADME/Tox Profiling of Natural Products: A Focus on BIOFACQUIM.天然产物的吸收、分布、代谢、排泄及毒理学特性分析:聚焦于 BIOFACQUIM
ACS Omega. 2020 Jun 25;5(26):16076-16084. doi: 10.1021/acsomega.0c01581. eCollection 2020 Jul 7.
6
Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds.通过对 6 亿种化合物的虚拟筛选鉴定出新型冠状病毒蛋白酶的潜在抑制剂。
Int J Mol Sci. 2020 May 21;21(10):3626. doi: 10.3390/ijms21103626.
7
Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study.海洋天然产物文库中 SARS-CoV-2 主蛋白酶的假定抑制剂:虚拟筛选和分子建模研究。
Mar Drugs. 2020 Apr 23;18(4):225. doi: 10.3390/md18040225.
8
Déjà vu: Stimulating open drug discovery for SARS-CoV-2.似曾相识:刺激针对 SARS-CoV-2 的开放药物研发。
Drug Discov Today. 2020 May;25(5):928-941. doi: 10.1016/j.drudis.2020.03.019. Epub 2020 Apr 19.
9
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study.通过计算药物再利用研究快速鉴定可能用于治疗冠状病毒病 19(COVID-19)的药物。
J Chem Inf Model. 2020 Jun 22;60(6):3277-3286. doi: 10.1021/acs.jcim.0c00179. Epub 2020 May 4.
10
Drug repurposing for coronavirus (COVID-19): screening of known drugs against coronavirus 3CL hydrolase and protease enzymes.冠状病毒(COVID-19)药物再利用:针对冠状病毒 3CL 水解酶和蛋白酶的已知药物筛选。
J Biomol Struct Dyn. 2021 May;39(8):2980-2992. doi: 10.1080/07391102.2020.1758791. Epub 2020 Apr 26.